{
    "timestamp": "Aug 12, 2025 5:35 PM EST",
    "stats": {
        "input_words": 1652148,
        "output_words": 1135,
        "filings_processed": 16
    },
    "filings": [
        {
            "company_name": "CBRE Group",
            "stock": "CBRE",
            "wiki_url": "https://en.wikipedia.org/wiki/CBRE_Group",
            "change_percent": 0,
            "price": 153.51,
            "filing_type": "8-K",
            "filing_time": "2025-08-12T17:05:51-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/1138118/000113811825000022/0001138118-25-000022-index.htm",
            "accession_number": "0001138118-25-000022",
            "summary_points": [
                "1. CBRE Group, Inc. announced that Lindsey Caplan will resign as Chief Accounting Officer on August 31, 2025, and depart the company entirely on December 31, 2025.",
                "2. Andrew Horn, the company's Deputy Chief Financial Officer since January 2025, will succeed Caplan as principal accounting officer, effective September 1, 2025.",
                "3.  There are no arrangements or understandings between Mr. Horn and any other persons pursuant to which he was selected for his position with the Company; no family relationships exist between Mr. Horn and any director or executive officer; and Mr. Horn has not participated in any related party transactions with the Company."
            ]
        },
        {
            "company_name": "PPL Corporation",
            "stock": "PPL",
            "wiki_url": "https://en.wikipedia.org/wiki/PPL_Corporation",
            "change_percent": 0,
            "price": 36.29,
            "filing_type": "8-K",
            "filing_time": "2025-08-12T16:35:03-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/922224/000092222425000039/0000922224-25-000039-index.htm",
            "accession_number": "0000922224-25-000039",
            "summary_points": [
                "1. On August 8th and 11th, 2025, PPL Corp entered into forward contracts to sell 27.4 million shares of common stock for approximately $984 million in expected net proceeds.",
                "2. Since February 2025, PPL Corp has executed forward contracts under its ATM program for approximately $1.4 billion of its common stock, reducing its previously disclosed expected equity need of $2.5 billion through 2028.",
                "3.  The forward contracts have settlement dates between December 30, 2025 and August 11, 2027."
            ]
        },
        {
            "company_name": "Molina Healthcare",
            "stock": "MOH",
            "wiki_url": "https://en.wikipedia.org/wiki/Molina_Healthcare",
            "change_percent": 0,
            "price": 153.81,
            "filing_type": "8-K",
            "filing_time": "2025-08-12T16:16:41-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/1179929/000143774925026208/0001437749-25-026208-index.htm",
            "accession_number": "0001437749-25-026208",
            "summary_points": [
                "1. Molina Healthcare, Inc. amended its Credit Agreement on August 12, 2025, adding a $500 million term loan (Term Loan A-2) maturing August 12, 2027, with a margin of 0.50% for base rate loans and 1.50% for SOFR-based loans.",
                "2. The company plans to use the Term Loan A-2 proceeds to temporarily fund its stock repurchase program,  due to the timing of subsidiary dividends later in 2025.",
                "3. The $500 million Term Loan A-2 represents a significant increase in Molina Healthcare's debt obligations, potentially impacting future financial performance and increasing financial risk."
            ]
        },
        {
            "company_name": "Dell Technologies",
            "stock": "DELL",
            "wiki_url": "https://en.wikipedia.org/wiki/Dell_Technologies",
            "change_percent": 0,
            "price": 138.34,
            "filing_type": "8-K",
            "filing_time": "2025-08-12T16:16:08-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/1571996/000157199625000093/0001571996-25-000093-index.htm",
            "accession_number": "0001571996-25-000093",
            "summary_points": [
                "1. On August 7, 2025, Brunilda Rios stepped down as Dell Technologies Inc.'s Chief Accounting Officer for personal reasons, though she remains a Senior Vice President.",
                "2. Richard Troy Sharp was appointed as Dell Technologies Inc.'s new Senior Vice President, Corporate Finance and Chief Accounting Officer, effective August 8, 2025, with an annual base salary of $368,100 and a target annual bonus equal to 55% of his base salary, pro-rated for the fiscal year ending January 30, 2026.",
                "3.  As of August 12, 2025, additional compensation details for Mr. Sharp's appointment have not yet been determined."
            ]
        },
        {
            "company_name": "C.H. Robinson",
            "stock": "CHRW",
            "wiki_url": "https://en.wikipedia.org/wiki/C.H._Robinson",
            "change_percent": 0,
            "price": 116.23,
            "filing_type": "8-K",
            "filing_time": "2025-08-12T16:16:07-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/1043277/000104327725000044/0001043277-25-000044-index.htm",
            "accession_number": "0001043277-25-000044",
            "summary_points": [
                "1. C.H. Robinson Worldwide, Inc. extended its receivables securitization facility's termination date to August 12, 2027, maintaining the committed funding at $500 million.",
                "2. Edward G. Feitzinger was elected to the company's board of directors on August 7, 2025.",
                "3.  No new information on future impacts or risks is provided beyond the extension of the receivables securitization facility."
            ]
        },
        {
            "company_name": "Akamai Technologies",
            "stock": "AKAM",
            "wiki_url": "https://en.wikipedia.org/wiki/Akamai_Technologies",
            "change_percent": 0,
            "price": 70.63,
            "filing_type": "8-K",
            "filing_time": "2025-08-12T16:08:10-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/1086222/000108622225000223/0001086222-25-000223-index.htm",
            "accession_number": "0001086222-25-000223",
            "summary_points": [
                "1. On August 11, 2025, Akamai Technologies' CEO and Chairman of the Board purchased 50,000 and 3,000 shares of company stock, respectively, at a weighted average price of approximately $72.26 and $72.30 per share.",
                "2. This 8-K filing indicates no material changes to Akamai Technologies' business or financial condition beyond the insider stock purchases.",
                "3.  No future impacts or risks are explicitly mentioned in this filing."
            ]
        },
        {
            "company_name": "Genuine Parts Company",
            "stock": "GPC",
            "wiki_url": "https://en.wikipedia.org/wiki/Genuine_Parts_Company",
            "change_percent": 0,
            "price": 133.41,
            "filing_type": "8-K",
            "filing_time": "2025-08-12T16:06:08-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/40987/000004098725000149/0000040987-25-000149-index.htm",
            "accession_number": "0000040987-25-000149",
            "summary_points": [
                "1. Genuine Parts Company declared a regular quarterly cash dividend of $1.03 per share on August 12, 2025, payable October 2, 2025, to shareholders of record on September 5, 2025.",
                "2.  The filing is an 8-K Current Report, indicating other events of importance occurred on August 12, 2025.",
                "3. The company is not classified as an emerging growth company."
            ]
        },
        {
            "company_name": "Roper Technologies",
            "stock": "ROP",
            "wiki_url": "https://en.wikipedia.org/wiki/Roper_Technologies",
            "change_percent": -1.17,
            "price": 527.67,
            "filing_type": "8-K",
            "filing_time": "2025-08-12T11:35:12-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/882835/000119312525178683/0001193125-25-178683-index.htm",
            "accession_number": "0001193125-25-178683",
            "summary_points": [
                "1. Roper Technologies Inc. issued $2,000,000,000 in senior unsecured notes on August 12, 2025, comprised of $500,000,000 in 4.250% notes due 2028, $500,000,000 in 4.450% notes due 2030, and $1,000,000,000 in 5.100% notes due 2035.",
                "2.  The notes were offered at 99.575% of principal for the 2028 notes, 99.201% for the 2030 notes, and 99.062% for the 2035 notes.",
                "3.  Upon a \"Change of Control Triggering Event,\" Roper Technologies is obligated to offer to repurchase the notes at 101% of principal plus accrued interest."
            ]
        },
        {
            "company_name": "Cardinal Health",
            "stock": "CAH",
            "wiki_url": "https://en.wikipedia.org/wiki/Cardinal_Health",
            "change_percent": 0.31,
            "price": 157.88,
            "filing_type": "10-K",
            "filing_time": "2025-08-12T08:58:00-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/721371/000072137125000079/0000721371-25-000079-index.htm",
            "accession_number": "0000721371-25-000079",
            "summary_points": [
                "1.  On August 12, 2025, the company announced an agreement to acquire Solaris Health for approximately $1.9 billion in cash, with an estimated $500 million in grant date fair value of common units issued to certain physicians and management.",
                "2.  Following the acquisition of Solaris Health, the company will own approximately 75% of The Specialty Alliance, its multi-specialty MSO platform.",
                "3. The total expense for employee retirement savings plans was $89 million in fiscal year 2025, compared to $65 million in 2024 and $66 million in 2023."
            ]
        },
        {
            "company_name": "Sherwin-Williams",
            "stock": "SHW",
            "wiki_url": "https://en.wikipedia.org/wiki/Sherwin-Williams",
            "change_percent": 0,
            "price": 354.7,
            "filing_type": "8-K",
            "filing_time": "2025-08-12T07:30:22-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/89800/000119312525178475/0001193125-25-178475-index.htm",
            "accession_number": "0001193125-25-178475",
            "summary_points": [
                "Failed to analyze filing"
            ]
        },
        {
            "company_name": "Cardinal Health",
            "stock": "CAH",
            "wiki_url": "https://en.wikipedia.org/wiki/Cardinal_Health",
            "change_percent": 0,
            "price": 157.88,
            "filing_type": "8-K",
            "filing_time": "2025-08-12T06:59:12-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/721371/000072137125000075/0000721371-25-000075-index.htm",
            "accession_number": "0000721371-25-000075",
            "summary_points": [
                "1. Cardinal Health's Q4 2025 revenue was $60.2 billion, relatively flat year-over-year but up 21% excluding a previously announced contract expiration.",
                "2. Fiscal year 2026 non-GAAP diluted EPS guidance was raised to $9.30-$9.50, a $0.20 increase from the previous outlook.",
                "3. Cardinal Health announced a definitive agreement to acquire Solaris Health for approximately $1.9 billion in cash,  expected to close by the end of calendar year 2025 and be slightly accretive to non-GAAP EPS in the first 12 months following the close."
            ]
        },
        {
            "company_name": "Celanese",
            "stock": "CE",
            "wiki_url": "https://en.wikipedia.org/wiki/Celanese",
            "change_percent": 0,
            "price": 47.29,
            "filing_type": "8-K",
            "filing_time": "2025-08-11T17:30:39-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/1306830/000110465925076253/0001104659-25-076253-index.htm",
            "accession_number": "0001104659-25-076253",
            "summary_points": [
                "Failed to analyze filing"
            ]
        },
        {
            "company_name": "Jack Henry & Associates",
            "stock": "JKHY",
            "wiki_url": "https://en.wikipedia.org/wiki/Jack_Henry_%26_Associates",
            "change_percent": 0,
            "price": 158.59,
            "filing_type": "8-K",
            "filing_time": "2025-08-11T16:53:33-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/779152/000077915225000049/0000779152-25-000049-index.htm",
            "accession_number": "0000779152-25-000049",
            "summary_points": [
                "1. Jack Henry & Associates, Inc. reported $20.5 million in deconversion revenue for the fiscal fourth quarter ended June 30, 2025, bringing the full fiscal year total to $33.9 million.",
                "2.  Deconversion revenue, excluded from non-GAAP revenue reporting, is driven by factors outside of Jack Henry's control and does not represent the company's ongoing business operations.",
                "3. The company issued a press release on August 11, 2025, announcing its deconversion revenue for the fiscal fourth quarter and full fiscal year ended June 30, 2025."
            ]
        },
        {
            "company_name": "Celanese",
            "stock": "CE",
            "wiki_url": "https://en.wikipedia.org/wiki/Celanese",
            "change_percent": 0,
            "price": 47.29,
            "filing_type": "10-Q",
            "filing_time": "2025-08-11T16:36:44-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/1306830/000130683025000174/0001306830-25-000174-index.htm",
            "accession_number": "0001306830-25-000174",
            "summary_points": [
                "1. As of June 30, 2025, Celanese had $725 million of remaining performance obligations related to take-or-pay contracts, with $269 million expected to be recognized as net sales in 2025, $238 million in 2026, and $114 million in 2027.",
                "2.  Celanese incurred $40 million in restructuring charges during the first six months of 2025, compared to $48 million during the same period in 2024.",
                "3. On August 11, 2025, Celanese replaced its U.S. Revolving Credit Facility with a new $1.75 billion senior unsecured revolving credit facility maturing in 2030, with a margin of 1.00% to 2.00% above certain interbank rates (or 0.00% to 1.00% for U.S. dollar base rate borrowings)."
            ]
        },
        {
            "company_name": "Lam Research",
            "stock": "LRCX",
            "wiki_url": "https://en.wikipedia.org/wiki/Lam_Research",
            "change_percent": 0,
            "price": 101.99,
            "filing_type": "10-K",
            "filing_time": "2025-08-11T16:35:11-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/707549/000070754925000075/0000707549-25-000075-index.htm",
            "accession_number": "0000707549-25-000075",
            "summary_points": [
                "1.  A 15-year tax incentive ruling in Malaysia, effective from fiscal year 2022, decreased worldwide taxes by approximately $584.8 million in fiscal year 2025.",
                "2.  Approximately $1.3 billion in earnings from foreign subsidiaries are indefinitely reinvested as of June 29, 2025; remitting these earnings to the US would incur approximately $152.1 million in foreign withholding taxes, offset by $121.7 million in foreign tax credits.",
                "3. The Omnibus Budget and Budget Reconciliation Act (OBBBA), signed into law on July 4, 2025, will impact income taxes in fiscal year 2026, and the company is assessing its potential implications."
            ]
        },
        {
            "company_name": "Celanese",
            "stock": "CE",
            "wiki_url": "https://en.wikipedia.org/wiki/Celanese",
            "change_percent": 0,
            "price": 47.29,
            "filing_type": "8-K",
            "filing_time": "2025-08-11T16:27:19-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/1306830/000130683025000173/0001306830-25-000173-index.htm",
            "accession_number": "0001306830-25-000173",
            "summary_points": [
                "1. Celanese Corporation's Q2 2025 adjusted EPS was $1.44, including $0.38 from transaction amortization.",
                "2. First-half 2025 free cash flow increased by approximately 80% year-over-year.",
                "3. Celanese projects a $35 million headwind to Q3 2025 EM adjusted EBIT due to weaker demand and inventory reductions."
            ]
        }
    ]
}